TEST DIRECTORY

0 selected

Laboratory:Hachioji

Oncomine Dx Target Test CDx System (FF)(Suspended beyond orders placed 02-27-2021)

  • TEST NAME SPECIMEN
    REQUIREMENT
    (mL)
    CONTAINER CAP COLOR STORE
    TEMPERATURE
    (STABILITY)
    TURNAROUND
    TIME (DAY)
    METHODOLOGY REFERENCE RANGE
    (UNIT)
  • INACTIVE Specified days
    Oncomine Dx Target Test CDx System (FF)(Suspended beyond orders placed 02-27-2021)
    tissue
    ARR Freeze
    11-14 Next Generation Sequencing (NGS)
other material

COMMENT


We analyzed the BRAF V600E gene mutation using genome DNA extracted from cancer tissues, and used the BRAF inhibitor "dabrafenib mesylate" and the MEK inhibitor "Trametinib dimethyl sulfoxide" for non-small cell lung cancer patients. Chemistry with methyl sulfoxide adducts The purpose is to determine the suitability of therapy (combined therapy).
Consignment days are Monday to Friday. Please confirm that the material contains the tumor site before submitting. Please avoid duplicate requests with other items. This testing method can be affected by contamination, so please be careful when handling the specimen.
When requesting this test, please be sure to also request the nucleic acid extraction item (item code number: M961 0).
●About materials other than tissue
Place the collected pleural fluid, alveolar lavage fluid, and bronchial scraping lavage fluid into a designated container (ARR) and centrifuge at room temperature (760G (2000-3000rpm) x 10 minutes). Please be sure to freeze and submit the sediment after removing as much of the supernatant as possible.
●Notes
After collecting the specimen, please process it immediately. Please note that if the amount of sample submitted is small, testing may not be possible.

CONTAINER

Related test

Notifications of URL changes/lab information added

ラボを選択してください

Choose a laboratory

Notifications of URL changes/lab information added

Laboratory List